Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by JasontheGreaton Jul 27, 2023 11:59am
186 Views
Post# 35559694

RE:RE:RE:RE:RE:RE:It's time for a takout

RE:RE:RE:RE:RE:RE:It's time for a takoutSorry man....i had to sell at $1.15 US when my average cost was around $6. SPECO was beating the drum on this stock when it dropped from $10 USD to $6. He and a few fanboys here were saying that this was a chance of a lifetime. They provided a ton of their analysis, theories, and articles to prove whatever they assumed. Paul was supposed to be a knight in shining armor coming in to save the company....I sunked $500k into this stupid stock. After I sold at $1.15 and used whatever I had left to buy Tesla shares, Ive literally 2.5x my money....IF I had held out, I would have lost another 100% and be where you guys are at now. 

SPECO should be called out even though it is not really his fault. If you were instrumental in giving your opinions, you should also be called out when youre flat out wrong. 
<< Previous
Bullboard Posts
Next >>